176 related articles for article (PubMed ID: 34610348)
1. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
Schumacher N; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
[TBL] [Abstract][Full Text] [Related]
2. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
[TBL] [Abstract][Full Text] [Related]
3. The metalloprotease ADAM17 in inflammation and cancer.
Düsterhöft S; Lokau J; Garbers C
Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
[TBL] [Abstract][Full Text] [Related]
4. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
[TBL] [Abstract][Full Text] [Related]
5. ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer.
Schumacher N; Rose-John S
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694340
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
[TBL] [Abstract][Full Text] [Related]
7. ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
Schmidt S; Schumacher N; Schwarz J; Tangermann S; Kenner L; Schlederer M; Sibilia M; Linder M; Altendorf-Hofmann A; Knösel T; Gruber ES; Oberhuber G; Bolik J; Rehman A; Sinha A; Lokau J; Arnold P; Cabron AS; Zunke F; Becker-Pauly C; Preaudet A; Nguyen P; Huynh J; Afshar-Sterle S; Chand AL; Westermann J; Dempsey PJ; Garbers C; Schmidt-Arras D; Rosenstiel P; Putoczki T; Ernst M; Rose-John S
J Exp Med; 2018 Apr; 215(4):1205-1225. PubMed ID: 29472497
[TBL] [Abstract][Full Text] [Related]
8. The shedding protease ADAM17: Physiology and pathophysiology.
Zunke F; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
[TBL] [Abstract][Full Text] [Related]
9. EGFR stimulation enables IL-6 trans-signalling via iRhom2-dependent ADAM17 activation in mammary epithelial cells.
Schumacher N; Thomsen I; Brundert F; Hejret V; Düsterhöft S; Tichý B; Schmidt-Arras D; Voss M; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119489. PubMed ID: 37271223
[TBL] [Abstract][Full Text] [Related]
10. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice.
Chalaris A; Adam N; Sina C; Rosenstiel P; Lehmann-Koch J; Schirmacher P; Hartmann D; Cichy J; Gavrilova O; Schreiber S; Jostock T; Matthews V; Häsler R; Becker C; Neurath MF; Reiss K; Saftig P; Scheller J; Rose-John S
J Exp Med; 2010 Aug; 207(8):1617-24. PubMed ID: 20603312
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the protease ADAM17 ameliorates experimental pancreatitis.
Saad MI; Weng T; Lundy J; Gearing LJ; West AC; Harpur CM; Alanazi M; Hodges C; Croagh D; Kumar B; Sagi I; Rose-John S; Jenkins BJ
Proc Natl Acad Sci U S A; 2022 Oct; 119(42):e2213744119. PubMed ID: 36215509
[TBL] [Abstract][Full Text] [Related]
12. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
[TBL] [Abstract][Full Text] [Related]
13. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
[TBL] [Abstract][Full Text] [Related]
14. Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.
Arnold P; Boll I; Rothaug M; Schumacher N; Schmidt F; Wichert R; Schneppenheim J; Lokau J; Pickhinke U; Koudelka T; Tholey A; Rabe B; Scheller J; Lucius R; Garbers C; Rose-John S; Becker-Pauly C
Sci Rep; 2017 Mar; 7():44053. PubMed ID: 28276471
[TBL] [Abstract][Full Text] [Related]
15. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
[TBL] [Abstract][Full Text] [Related]
16. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
Lu F; Zhao H; Dai Y; Wang Y; Lee CH; Freeman M
Mol Cell; 2024 Jun; 84(11):2152-2165.e5. PubMed ID: 38781971
[TBL] [Abstract][Full Text] [Related]
18. The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis.
Saad MI; McLeod L; Yu L; Ebi H; Ruwanpura S; Sagi I; Rose-John S; Jenkins BJ
Carcinogenesis; 2020 Jun; 41(4):527-538. PubMed ID: 31257400
[TBL] [Abstract][Full Text] [Related]
19. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
Al-Salihi MA; Lang PA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
[TBL] [Abstract][Full Text] [Related]
20. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.
Lorenzen I; Lokau J; Düsterhöft S; Trad A; Garbers C; Scheller J; Rose-John S; Grötzinger J
FEBS Lett; 2012 Apr; 586(8):1093-100. PubMed ID: 22575642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]